NCT04248101 (RCT) is a Phase 2 clinical trial of Double Ligation in Umbilical Granuloma, sponsored by Shaheed Zulfiqar Ali Bhutto Medical University.

Who is sponsoring NCT04248101?

NCT04248101 is sponsored by Shaheed Zulfiqar Ali Bhutto Medical University.

What drugs are being tested in NCT04248101?

Interventions in NCT04248101: Double Ligation, Topical Silver Nitrate.

What condition does NCT04248101 study?

NCT04248101 studies Umbilical Granuloma.

Is NCT04248101 still recruiting?

NCT04248101 is currently completed. Last updated 30 January 2020.

Last reviewed 2020-01-30 · How we verify

NCT04248101: RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Double Ligation and Topical Silver Nitrate

Completed Phase 2 Last updated 30 January 2020

What this trial tests

Phase 2 trial testing Double Ligation in Umbilical Granuloma in 176 participants. Completed in 1 July 2017.

Timeline

1 July 2016

Primary endpoint
30 June 2017

1 July 2017

Quick facts

Lead sponsor	Shaheed Zulfiqar Ali Bhutto Medical University
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	176
Start date	1 July 2016
Primary completion	30 June 2017
Estimated completion	1 July 2017

Drugs / interventions tested

Double Ligation
Topical Silver Nitrate — full drug profile →

Conditions studied

Umbilical Granuloma — all drugs for Umbilical Granuloma →

Sponsor

Shaheed Zulfiqar Ali Bhutto Medical University

Who can join

Under 12 Months, any sex, with Umbilical Granuloma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study and compare the efficacy and safety of Double Ligation and Topical Silver Nitrate Solution while treating children with Umbilical Granulomas

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Shaheed Zulfiqar Ali Bhutto Medical University trials

Trials by the same sponsor.

NCT06525844 — Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis · NA · recruiting
NCT06176430 — Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy · Phase 4 · unknown
NCT06234020 — Frequency of Vertebrospinal Anomalies in Patients Presenting With Anorectal Malformations · completed
NCT06323642 — Role of Probiotics as Adjunct Therapy Along With Standard Care in Decreasing Hospital Stay and Improving Symptoms in Ped · NA · unknown
NCT06164158 — Role of Procedural Videos in Teaching the Surgery Residents · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04248101 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shaheed Zulfiqar Ali Bhutto Medical University
Last refreshed: 30 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04248101.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing